Antitumor impact of p14ARF on gefitinib-resistant non-small cell lung cancers.
Saito K, Takigawa N, Ohtani N, Iioka H, Tomita Y, Ueda R, Fukuoka J, Kuwahara K, Ichihara E, Kiura K, Kondo E.
Saito K, et al. Among authors: kondo e.
Mol Cancer Ther. 2013 Aug;12(8):1616-28. doi: 10.1158/1535-7163.MCT-12-1239. Epub 2013 Jun 12.
Mol Cancer Ther. 2013.
PMID: 23761220